申请人:Recordati S.A.
公开号:US04634712A1
公开(公告)日:1987-01-06
##STR1## Esters I (Ar=3-nitrophenyl or 2,3-dichlorophenyl, A=C.sub.2 -C.sub.6 alkylene, R=C.sub.1 -C.sub.6 alkyl optionally C.sub.1 -C.sub.6 alkoxy monosubstituted, R.sub.1 =C.sub.1 -C.sub.4 alkyl) have antihypertensive activity and are effective against coronary heart diseases. They are prepared starting from the aldehyde ArCHO and esters of acetoacetic acid and 3-aminocrotonic acid. Pharmaceutical preparations containing them are also described.
Esters I(Ar=3-硝基苯基或2,3-二氯苯基,A=C.sub.2-C.sub.6烷基,R=C.sub.1-C.sub.6烷基,可选C.sub.1-C.sub.6烷氧单取代,R.sub.1=C.sub.1-C.sub.4烷基)具有降压活性,并对冠心病有效。它们是从醛ArCHO和乙酰乙酸酯和3-氨基巴豆酸酯开始制备的。还描述了含有它们的制药制剂。